Abstract: A novel eco-friendly method has been developed for the fabrication of high dense (3.3-5.2 g/cc) red mud based material blocks for shielding high energy X- and ?-rays. The red mud based material blocks with various densities were fabricated by hot compacting partially melted red mud, red mud:Bi2O3, red mud:Ba(OH)2 and red mud:Bi2O3:Ba(OH)2 samples at 1150° C., 1000° C., 1050° C. and 1000° C., respectively. This material can be used to build radiation shielding structures in medical diagnosis, radiotherapy, industrial radiography, particle accelerators, food sterilization plants, nuclear power plants, and radioactive material storage rooms, without further structural support unlike lead (concrete walls). It is economically viable and will suppress the accumulation of hazardous red mud and associated environmental pollutions.

Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.

Abstract: The novel process enables designing of raw materials and processing parameters, enabling synergistic and simultaneous chemical reactions among the various reactants of the design mix of chemical precursor of brine sludge which includes barium sulphate, magnesium hydroxide, calcium carbonate, sodium chloride, silica, aluminum containing compounds necessary for developing highly efficient shielding phases leading to homogenous matrix of shielding materials.

Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.

Abstract: The present invention relates to a multifunctional hybrid particle board and a process for manufacturing hybrid unlaminated and laminated green composite particle boards/fibre board and panels with variable density, mechanical strength, thermal conductivity and water absorption with epoxy and polyester resin system under compression moulding machine. Preparation process describe a process to effectively utilise agro-residues/particulates/fibres to avoid its burning and resultant air and environmental pollution. The applications of the fabricated unlaminated and laminated hybrid particle board for use in architectural cladding panels, partition panels, wall panels.

Abstract: The present invention relates to a lead free glossy finish hybrid radiation shielding composite panel comprising: a) 40-70% of industrial waste red mud and 30-60% of epoxy/polyester resin with or without glass fibre, wherein the composite panel has density in the range of 1.4-2.2 g/cc; water absorption in the range of 0.20-0.30%; tensile strength in the range of 12-120 MPa; tensile modulus in the range of 1.5-7.5 GPa; and half value layer in the range of 0.36-0.47 cm and 0.48-0.52 cm for X-ray beam energies of 60 and 100 kVp, respectively. The present invention also describes a low temperature process for manufacturing the composite panels. Moreover, the developed composite panel is a unique material and have multifunctional applications in wider spectrum as high energy electromagnetic radiation shielding doors, panels, partition panels and as roofing sheets.

Abstract: The present invention relates to advanced multi-functional asbestos-free thermal insulating materials utilizing appropriate matrixes comprising nano thermal insulating precursor powder predominantly comprising calcium silicate and calcium magnesium silicate prepared from marble waste powder, rice husk and calcium hexametaphosphate; crushed silica fiberglass and a supporting matrix.

Abstract: The novel process enables designing of raw materials and processing parameters, enabling synergistic and simultaneous chemical reactions among the various reactants of the design mix of chemical precursor of brine sludge which includes barium sulphate, magnesium hydroxide, calcium carbonate, sodium chloride, silica, aluminum containing compounds necessary for developing highly efficient shielding phases leading to homogenous matrix of shielding materials.

Abstract: The present invention provides a glossy finish sandwich composite, comprising face sheet as skin element and a core element; wherein, the skin element is a composite selected from the group consisting of inorganic industrial waste particulates reinforced polymeric composite; fibres reinforced polymeric composite; and fibres and particulate reinforced hybrid polymer composite; wherein, the core element is selected from the group consisting of polyurethane foam and wastes reinforced polymeric material. The present invention also provides a novel process for developing glossy finish high performance hybrid sandwich composite(s). Moreover, the sandwich composite(s) of the present invention are unique materials which have versatile applications in wider spectrum of utility in sustainable manner and address issues on waste management, effective utilisation of renewable resources and agro-wastes.

Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.

Abstract: The present invention relates to advanced multi-functional asbestos-free thermal insulating materials utilizing appropriate matrixes comprising nano thermal insulating precursor powder predominantly comprising calcium silicate and calcium magnesium silicate prepared from marble waste powder, rice husk and calcium hexametaphosphate; crushed silica fiberglass and a supporting matrix.

Abstract: The present invention deals with development of a novel process for manufacturing moisture resistant glossy finish hybrid green polymeric composites with variable density in range of 0.2-1.68 g/cc, low water/moisture absorption in the range of 0.1-1.3%, tensile strength and tensile modulus in range of 6.5-105 MPa and 250-6850 MPa, respectively and to the best of our knowledge the fabricated hybrid green composites has not yet developed universally using different types of industrial wastes particulates. Moreover, hybrid composites developed using industrial wastes, natural fibres and epoxy/polyester/polyurethane polymers is a unique materials and have multifunctional applications in wider spectrum as an alternative to wood, synthetic wood, wood plastic composites, screen printing sheet, plastic, fibre and glass reinforced polymer products, including tin sheet.

Abstract: Human cathepsin L inhibitors and probes containing a vinyl sulfonate ester moiety are described. The inhibitors are highly potent (low nM affinity), selective, and cell permeable, and can inhibit ultra-low concentration of active cathepsin L. The developed probes are highly sensitive and can detect an ultra-low amount of probe-labeled active cathespin L.

Abstract: Human cathepsin L inhibitors and probes containing a vinyl sulfonate ester moiety are described. The inhibitors are highly potent (low nM affinity), selective, and cell permeable, and can inhibit ultra-low concentration of active cathepsin L. The developed probes are highly sensitive and can detect an ultra-low amount of probe-labeled active cathespin L.

Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.

Abstract: Provided are compounds capable of covalently binding to a protein tyrosine phosphatase (PTP). The compounds comprise Formula A: Also provided are compositions comprising one of the above compounds covalently bound to a member of the PTP superfamily, methods of labeling a PTP using the compounds, methods of isolating a PTP from a mixture of proteins using the compounds, methods of evaluating whether a substance is an inhibitor of a PTP using the compounds, methods of evaluating the specificity of an inhibitor of a PTP using the compounds, methods of identifying a PTP involved in a disease in a mammal using the compounds, and methods of diagnosing a disease in a mammal using the compounds.

Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.

Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.

Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.

Abstract: Provided are compounds capable of covalently binding to a protein tyrosine phosphatase (PTP). The compounds comprise Formula A: Also provided are compositions comprising one of the above compounds covalently bound to a member of the PTP superfamily, methods of labeling a PTP using the compounds, methods of isolating a PTP from a mixture of proteins using the compounds, methods of evaluating whether a substance is an inhibitor of a PTP using the compounds, methods of evaluating the specificity of an inhibitor of a PTP using the compounds, methods of identifying a PTP involved in a disease in a mammal using the compounds, and methods of diagnosing a disease in a mammal using the compounds.